Charles Consultants
Stories naming Chris Gardner. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
The US medicines regulator has granted Fast Track designation to Aravax's peanut-allergy immunotherapy PVX108, easing its development path; the Melbourne-based biotech expects Phase 2 data later in 2026.
Roundup of six Australian funding deals: AutoGrab, Applied EV, Checkbox, Hometime, Factory and On the House, with amounts, investors, and Hometime's past acquisitions and raise history detailed.
Also Startup Daily
Melbourne car-data platform AutoGrab has closed an $80 million Series B valuing it at $230 million, co-led by Octopus Ventures and Movac, to fund expansion across Britain, Europe and Asia-Pacific.
Vehicle-data platform AutoGrab has raised $80 million led by Octopus Ventures and Movac, valuing the company at $230 million, alongside Premier Capital Partners and existing backers EVP and Ten13.
Also Startup Daily·inspirepreneurmagazine.com·paintandpanel.com.au·autoworldjournal.com·autotalk.com.au·SmartCompany·Startup Daily
TEN13's investor letter celebrates passing $100 million deployed, plus fresh backing for iion and Switchboard, team promotions, AutoGrab's overseas growth and NZ-arm sale, and the Mr Yum–Me&U merger.
Pain-drug developer Spinifex Pharmaceuticals hires Dr Ronald Marcus as chief medical officer; CEO Tom McCarthy cites a recent $45 million raise backing further phase 2 trials of EMA401.